Who
Sanitam Partners LLC
10% owner
Company insider
Files Form 4 as: 10% owner, Matinas Biopharma Holdings.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 Apr 2025
- Last trade
- 10 Jun 2026
- Last filed
- 13 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code J | $8241,406 at $0.586 | filing |
| 10 Jun 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code J | $3.1M4,798,636 at $0.6446 | filing |
| 10 Jun 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code J | $8301,406 at $0.59 | filing |
| 10 Jun 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code J | $3.1M4,798,636 at $0.64 | filing |
| 8 Apr 2025filed 10 Apr 2025 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code P | $703K703 at $1,000.00 | filing |
| 8 Apr 2025filed 10 Apr 2025 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,399,318 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.